Description: Pfizer CEO Albert Bourla on Monday said the pharmaceutical giant will be able to deliver Seagen’s cancer therapy to the world “at a scale that has not been seen before” with its $43 billion acquisition.
Source: CNBC.com – video reports
Date: Mar 13, 2023
Questions for discussion:
- Explain the logic of this acquisition for both firms.
- Is it a good financial deal for both firms?
- How will this deal likely affect industry-development of the technology involved?
Leave a Reply
You must be logged in to post a comment.